None
Quote | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
Last: | $1.90 |
---|---|
Change Percent: | 0.0% |
Open: | $1.89 |
Close: | $1.90 |
High: | $1.925 |
Low: | $1.84 |
Volume: | 155,696 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
News | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat...
2024-05-10 09:46:10 ET More on Checkpoint Therapeutics Seeking Alpha’s Quant Rating on Checkpoint Therapeutics Historical earnings data for Checkpoint Therapeutics Financial information for Checkpoint Therapeutics Read the full article on Seeking Alp...
Message Board Posts | Checkpoint Therapeutics Inc. (NASDAQ:CKPT)
Subject | By | Source | When |
---|---|---|---|
$CKPT............................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g | glenn1919 | investorshub | 04/29/2023 12:50:02 PM |
$CKPT.......................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g=0&id | glenn1919 | investorshub | 04/22/2023 12:17:50 PM |
$CKPT.....................https://stockcharts.com/h-sc/ui?s=$CKPT&p=W&b=5&g=0&id=p | glenn1919 | investorshub | 04/15/2023 7:26:28 PM |
This stock sure is volatile!! | vein | investorshub | 01/18/2023 2:54:08 PM |
Yeah , especially with the rise in stock price | vein | investorshub | 01/14/2023 6:05:59 PM |
News, Short Squeeze, Breakout and More Instantly...
Checkpoint Therapeutics Inc. Company Name:
CKPT Stock Symbol:
NASDAQ Market:
LOS ANGELES, May 28, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class a...
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage immunotherapy and ...
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat...